Lentivirus vector can be readministered to nasal epithelia without blocking immune responses

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10684-10692

  Sinn, Patrick L ^a   Arias, Ariadna C ^a   Brogden, Kim A ^b   McCray Jr , Paul B ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BACULOVIRUS VECTOR; BETA GALACTOSIDASE; FELINE IMMUNODEFICIENCY VIRUS VECTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LENTIVIRUS VECTOR; NEUTRALIZING ANTIBODY; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; LUCIFERASE; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HEMATOCRIT; INNATE IMMUNITY; MOUSE; NONHUMAN; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BAGG ALBINO MOUSE; BLOOD; FELINE IMMUNODEFICIENCY VIRUS; GENE THERAPY; GENE VECTOR; GENETICS; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; RESPIRATORY TRACT MUCOSA; SERODIAGNOSIS;

ADENOVIRIDAE; FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MURINAE;

ANIMALS; ANTIBODIES, VIRAL; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; IMMUNODEFICIENCY VIRUS, FELINE; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RESPIRATORY MUCOSA; TRANSDUCTION, GENETIC;

EID: 55249121439     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00227-08     Document Type: Article

References (46)

1. Aitken, M. L., R. B. Moss, D. A. Waltz, M. E. Dovey, M. R. Tonelli, S. C. McNamara, R. L. Gibson, B. W. Ramsey, B. J. Carter, and T. C. Reynolds. 2001. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12:1907-1916.
2. Auricchio, A., E. O'Connor, D. Weiner, G. P. Gao, M. Hildinger, L. Wang, R. Calcedo, and J. M. Wilson. 2002. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J. Clin. Investig. 110:499-504.
3. Borgland, S. L., G. P. Bowen, N. C. W. Wong, T. A. Libermann, and D. A. Muruve. 2000. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-κB. J. Virol. 74:3941-3947.
4. Bowen, G. P., S. L. Borgland, M. Lam, T. A. Libermann, N. C. Wong, and D. A. Muruve. 2002. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum. Gene Ther. 13:367-379.
5. Brown, B. D., G. Sitia, A. Annoni, E. Hauben, L. S. Sergi, A. Zingale, M. G. Roncarolo, L. G. Guidotti, and L. Naldini. 2007. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109:2797-2805.
6. Chillon, M., J. H. Lee, A. Fasbender, and M. J. Welsh. 1998. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther. 5:995-1002.
7. Copreni, E., M. Penzo, S. Carrabino, and M. Conese. 2004. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther. 11(Suppl. 1):S67-S75.
8. Cruz-Orive, L. M., and E. R. Weibel. 1981. Sampling designs for stereology. J. Microsc. 122:235-257.
9. Davis, B., J. Nguyen, D. Stoltz, D. Depping, K. J. Excoffon, and J. Zabner. 2004. Adenovirus-mediated erythropoietin production by airway epithelia is enhanced by apical localization of the coxsackie-adenovirus receptor in vivo. Mol. Ther. 10:500-506.
10. Dropulic, B., and C. H. June. 2006. Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Hum. Gene Ther. 17:577-588.
11. Fong, T. C., S. L. Sauter, C. E. Ibanez, P. L. Sheridan, and D. J. Jolly. 2000. The use and development of retroviral vectors to deliver cytokine genes for cancer therapy. Crit. Rev. Ther. Drug Carrier Syst. 17:1-60.
12. Gao, G., L. H. Vandenberghe, and J. M. Wilson. 2005. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5:285-297.
13. Goldman, M. J., P. S. Lee, J. S. Yang, and J. M. Wilson. 1997. Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 8:2261-2268.
14. Halbert, C. L., A. D. Miller, S. McNamara, J. Emerson, R. L. Gibson, B. Ramsey, and M. L. Aitken. 2006. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: implications for gene therapy using AAV vectors. Hum. Gene Ther. 17:440-447.
15. Harvey, B. G., N. R. Hackett, S. Ely, and R. G. Crystal. 2001. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals. Mol. Ther. 3:206-215.
16. Harvey, B. G., P. L. Leopold, N. R. Hackett, T. M. Grasso, P. M. Williams, A. L. Tucker, R. J. Kaner, B. Ferris, I. Gonda, T. D. Sweeney, R. Ramalingam, I. Kovesdi, S. Shak, and R. G. Crystal. 1999. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Investig. 104:1245-1255.
17. Higginbotham, J. N., P. Seth, R. M. Blaese, and W. J. Ramsey. 2002. The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. Hum. Gene Ther. 13:129-141.
18. Jarvis, D. L., and E. E. Finn. 1995. Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology 212:500-511.
19. Johnson, L. G., J. P. Mewshaw, H. Ni, T. Friedmann, R. C. Boucher, and J. C. Olsen. 1998. Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J. Virol. 72:8861-8872.
20. Johnson, L. G., J. C. Olsen, L. Naldini, and R. C. Boucher. 2000. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther. 7:568-574.
21. Johnston, J. C., M. Gasmi, L. E. Lim, J. H. Elder, J.-K. Yee, D. J. Jolly, K. P. Campbell, B. L. Davidson, and S. L. Sauter. 1999. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73:4991-5000.
22. Keriel, A., C. René, C. Galer, J. Zabner, and E. J. Kremer. 2006. Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors. J. Virol. 80:1487-1496.
23. Kobinger, G. P., D. J. Weiner, Q. C. Yu, and J. M. Wilson. 2001. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:225-230.
24. Koehler, D. R., B. Martin, M. Corey, D. Palmer, P. Ng, A. K. Tanswell, and J. Hu. 2006. Readministration of helper-dependent adenovirus to mouse lung. Gene Ther. 13:773-780.
25. Leavell, S., B. Wright, L. Scappino, J. Sirriyah, C. Chen, J. D. Clements, and M. J. Burkhard. 2005. Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag. Vaccine 23:1471-1478.
26. Levine, B. L., L. M. Humeau, J. Boyer, R. R. MacGregor, T. Rebello, X. Lu, G. K. Binder, V. Slepushkin, F. Lemiale, J. R. Mascola, F. D. Bushman, B. Dropulic, and C. H. June. 2006. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA 103:17372-17377.
27. Limberis, M., D. S. Anson, M. Fuller, and D. W. Parsons. 2002. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum. Gene Ther. 13:1961-1970.
28. Limberis, M. P., and J. M. Wilson. 2006. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. USA 103:12993-12998.
29. Lindley, K. M., J. L. Su, P. K. Hodges, G. B. Wisely, R. K. Bledsoe, J. P. Condreay, D. A. Winegar, J. T. Hutchins, and T. A. Kost. 2000. Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins. J. Immunol. Methods 234:123-135.
30. Lu, X., Z. Kurago, and K. A. Brogden. 2006. Effects of polymicrobial communities on host immunity and response. FEMS Microbiol. Lett. 265:141-150.
31. Lu, X., L. C. Pingel, K. K. Burnell, J. E. Cavanaugh, and K. A. Brogden. 2007. Carbamoylcholine chloride induces a rapid increase in IL6 in the nasal cavity of C57BL/6 mice. Comp. Med. 57:349-354.
32. Luna, L. G. 1992. Histopathologic methods and color atlas of special stains and tissue artifacts. Johnson Printers, Downers Grove, IL.
33. Mastrangeli, A., B. G. Harvey, J. Yao, G. Wolff, I. Kovesdi, R. G. Crystal, and E. Falck-Pedersen. 1996. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7:79-87.
34. McCormack, J. E., D. Martineau, N. DePolo, S. Maifert, L. Akabarian, K. Townsend, W. Lee, M. Irwin, N. Sajjadi, D. J. Jolly, and J. Warner. 1997. Anti-vector immunoglobulin induced by retroviral vectors. Hum. Gene Ther. 8:1263-1273.
35. McKay, T., M. Patel, R. J. Pickles, L. G. Johnson, and J. C. Olsen. 2006. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther. 13:715-724.
36. Moss, R. B., C. Milla, J. Colombo, F. Accurso, P. L. Zeitlin, J. P. Clancy, L. T. Spencer, J. Pilewski, D. A. Waltz, H. L. Dorkin, T. Ferkol, M. Pian, B. Ramsey, B. J. Carter, D. B. Martin, and A. E. Heald. 2007. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum. Gene Ther. 18:726-732.
37. Sinn, P. L., E. R. Burnight, M. A. Hickey, G. W. Blissard, and P. B. McCray, Jr. 2005. Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J. Virol. 79: 12818-12827.
38. Sinn, P. L., J. D. Goreham-Voss, A. C. Arias, M. A. Hickey, W. Maury, C. P. Chikkanna-Gowda, and P. B. McCray, Jr. 2007. Enhanced gene expression conferred by stepwise modification of a non-primate lentiviral vector. Hum. Gene Ther. 18:1244-1252.
39. Sinn, P. L., S. L. Sauter, and P. B. McCray, Jr. 2005. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors - design, biosafety, and production. Gene Ther. 12:1089-1098.
40. Sinn, P. L., A. Shah, M. Donovan, and P. B. McCray, Jr. 2005. Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am. J. Respir. Cell Mol. Biol. 32:404-410.
41. Stein, C. S., J. L. Pemberton, N. van Rooijen, and B. L. Davidson. 1998. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus. Gene Ther. 5:431-439.
42. Tami, C., A. Peralta, R. Barbieri, A. Berinstein, E. Carrillo, and O. Taboga. 2004. Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces. Vaccine 23:840-845.
43. Wang, G., V. Slepushkin, J. Zabner, S. Keshavjee, J. C. Johnston, S. L. Sauter, D. J. Jolly, T. W. Dubensky, Jr., B. L. Davidson, and P. B. McCray, Jr. 1999. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Investig. 104:R55-R62.
44. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
45. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209-7212.
46. Zabner, J., B. W. Ramsey, D. P. Meeker, M. L. Aitken, R. P. Balfour, R. L. Gibson, J. Launspach, R. A. Moscicki, S. M. Richards, T. A. Standaert, et al. 1996. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Investig. 97:1504-1511.